• 2003

Company Description

MetaCure develops implantable devices for the treatment of Type II (adult) diabetes.

MetaCure develops implantable devices for the treatment of Type II (adult) diabetes. Their key product, Tantalus, delivers electrical pulses to the stomach when a person eats, causing gastric contractions.